Efficacy of a Methylphenidate Transdermal System Versus t.i.d. Methylphenidate in a Laboratory Setting

Journal of Attention Disorders

Volumn 15, Issue 1, 2010, Pages 28-35

  Pelham, William E ^a   Waxmonsky, James G ^a   Schentag, Jerome ^a   Ballow, Charles H ^b   Panahon, Carlos J ^c   Gnagy, Elizabeth M ^a   Hoffman, Martin T ^a   Burrows MacLean, Lisa ^a   Meichenbaum, David L ^d   Forehand, Gregory L ^e   Fabiano, Gregory A ^a   Tresco, Katy E ^f   Lopez Williams, Andy ^d   Coles, Erika K ^g   González, Mario A ^d  

^a UNIVERSITY AT BUFFALO   (United States)

^b Buffalo Clinical Research Center   (United States)

^c MINNESOTA STATE UNIVERSITY   (United States)

^d Summit Educational Resources ^*  (United States)

^e Northwest Reg Educ Laboratory   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g UNIVERSITY OF MAINE   (United States)

Author keywords

ADHD; Methylphenidate; transdermal

Indexed keywords

CENTRAL STIMULANT AGENT; METHYLPHENIDATE;

ANALYSIS OF VARIANCE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; METHYLPHENIDATE; TREATMENT OUTCOME;

EID: 78650161581     PISSN: 10870547     EISSN: 15571246     Source Type: Journal    
DOI: 10.1177/1087054709359163     Document Type: Article

References (21)

1. Daytrana [package insert]. Wayne, PA; Shire US Inc; 2009.
2. Findling, R.L., Bukstein, O.G., Melmed, R.D., Lopez, F.A., Sallee, F.R., Arnold, L.E.,et al.(2008). A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention deficit hyperactivity disorder. Journal of Clinical Psychiatry, 69, 149-159.
3. Gau, S.F., Shen, H.Y., Chou, M.C., Tang, C.S., Chiu, Y.N., & Gau, C.S. (2006). Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. Journal of Child and Adolescent Psychopharmacology, 16, 286-297.
4. Loney, J., & Milich, R. (1982). Hyperactivity, inattention, and aggression in clinical practice. In M. Wolraich & D. K. Routh (Eds.), Advances in developmental and behavioral pediatrics (pp. 113-147). Greenwich, Conn: JAI Press.
5. McGough, J.J., Wigal, S.B., Abikoff, H., Turnbow, J.M., Posner, K., & Moon, E. (2006). A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with attention deficit hyperactivity disorder. Journal of Attention Disorders, 9, 476-485.
6. Muniz, R., Brams, M., Mao, A., McCague, K., Pestreich, L., & Silva, R. (2008). Efficacy and safety of extended-release demethylphendiate compared with d, l-mehtyphenidate and placebo in the treatment of children with attention deficit hyperactivity disorder: A 12 hour laboratory classroom study. Journal of Child and Adolescent Psychopharmacology, 18, 248-256.
7. Pelham, W.E., Burrows-MacLean, L., Gnagy, E.M., Fabiano, G.A., Coles, E.K., Tresco, K.E.,et al.(2005). Transdermal methylphenidate, behavioral, and combined treatment for children with attention deficit hyperactivity disorder. Experimental and Clinical Psychopharmacology, 13, 111-126.
8. Pelham, W.E., Carlson, C.L., Sams, S.E., Vallano, G., Dixon, M.J., & Hoza, B. (1993). Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit hyperactivity disorder in the classroom. Journal of Consulting and Clinical Psychology, 61, 506-515.
9. Pelham, W.E., Gnagy, E.M., Burrows-MacLean, L., Williams, A., Fabiano, G.A., Morrisey, S.M.,et al.(2001). Once-a-day concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics, 107, e105.
10. Pelham, W.E., Gnagy, E.M., Greenslade, K.E., & Milich, R. (1992). Teacher ratings of DSM IIIR symptoms for the disruptive behavior disorders. Journal of American Academy of Child and Adolescent Psychiatry, 31, 210-218.
11. Pelham, W.E., Manos, M.J., Ezzell, C.E., Tresco, K.E., Gnagy, E.M., Hoffman, M.T.,et al.(2005). A dose ranging study of a methylphenidate transdermal system in children with attention deficit hyperactivity disorder. Journal of American Academy of Child and Adolescent Psychiatry, 44, 522-529.
12. Pelham, W.E., Massetti, G.M., & Fabiano, G.A. (2005). Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents. Journal of Clinical Child & Adolescent Psychology, 34, 449-476.
13. Pierce, D., Dixon, C., Wigal, S., & McGough, J. (2008). Pharmacokinetics of methylphenidate trasndermal system (MTS): Results from a laboratory classroom study. Journal of Child and Adolescent Psychopharmacology, 18, 355-364.
14. Pliszka, S. (2007). AACAP-Work-Group-on-Quality-Issues Practice parameter for the assessment and treatment of children and adolescents with attention deficit/hyperactivity disorder. Journal of American Academy of Child and Adolescent Psychiatry, 46, 894-921.
15. Shaffer, D., Fisher, P., Lucas, C.P., Dulcan, M.K., & Schwab-Stone, M.E. (2000). NIMH diagnostic interview schedule for children version IV (NIMH DISC-IV): Description, differences from previous versions, and reliability of some common diagnoses. Journal of Ameican Academy of Child and Adolescent Psychiatry, 39, 28-38.
16. Steele, M., Weiss, M., Swanson, J., Wang, J., Prinzo, R.S., & Binder, C.E. (2006). A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit hyperactivity disorder. Canadian Journal of Clinical Pharmacology, 13, e50-62.
17. Swanson, J., Lerner, M., Wigal, T., Steinhoff, K., Greenhill, L., Posner, K.,et al.(2002). The use of laboratory school protocol to evaluate conecpts about the efficiacy and side effects of new formulations of stimulant medications. Journal of Attention Disorders, 6, S73-88.
18. Swanson, J., Wigal, S., Wigal, T., Sonuga-Barke, E., Greenhill, L., Biederman, J.,et al.(2004). COMACS Study Group. A comparison of once-daily extended-release methylphenidate formulations in children with attention deficit hyperactivity disorder in the laboratory school (The Comacs Study). Pediatrics, 113, e206-216.
19. Waschbusch, D., Pelham, W., Waxmonsky, J., & Johnson, C. (2009). Are there placebo effects in the medication treatment of children with ADHD? Journal of Developmental and Behavioral Pediatrics, 30, 158-168.
20. Wechsler, D. (1991). Wechsler Intelligence Scale for Children- Third Edition. New York: Psychological Corporation.
21. Weisler, R.H. (2007). Review of long acting stimulants in the treatment of attention deficit hyperactivity disorder. Expert Opinion on Pharmacotherapy, 8, 745-758.